Dark Matter Therapeutics, Inc.

Biotechnology company · Wilmington, Delaware, United States

Dark Matter Therapeutics, Inc. is a biotechnology company headquartered in Wilmington, Delaware, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $399,414 in total, most recently in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Dark Matter Therapeutics at a glance

Typebiotechnology company
HeadquartersWilmington, Delaware, United States
Employees (self-reported, 2025)3

What does Dark Matter Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $399,414 in total (2025). NIH funding came from the National Institute on Drug Abuse.

Frequently asked questions about Dark Matter Therapeutics

Where is Dark Matter Therapeutics headquartered?

Dark Matter Therapeutics, Inc. is headquartered in Wilmington, Delaware, United States.

What does Dark Matter Therapeutics do?

Dark Matter Therapeutics, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences